thrombophilia
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| thrombophilia [2023/10/19 21:54] – [introduction] gary1 | thrombophilia [2026/07/07 10:48] (current) – [introduction] gary1 | ||
|---|---|---|---|
| Line 22: | Line 22: | ||
| *other haematologic conditions predisposing to thrombosis: | *other haematologic conditions predisposing to thrombosis: | ||
| * [[JAK|JAK2 V617F mutation]] with or without [[essential_thrombocytosis]] or overt myeloproliferative neoplasm mainly associated with splanchnic vein or cerebral vein thromboses | * [[JAK|JAK2 V617F mutation]] with or without [[essential_thrombocytosis]] or overt myeloproliferative neoplasm mainly associated with splanchnic vein or cerebral vein thromboses | ||
| + | * a 2026 study suggests another 494 genes are associated with thrombophilic risk(([[https:// | ||
| * **high VTE polygenic risk score people** | * **high VTE polygenic risk score people** | ||
| * polygenic risk score for DVT includes rs6025 (FVL) (effect allele T; allele frequency, 0.02) in the F5 gene and rs1799963 (PTM) (effect allele A; allele frequency, 0.01) in the F2 gene | * polygenic risk score for DVT includes rs6025 (FVL) (effect allele T; allele frequency, 0.02) in the F5 gene and rs1799963 (PTM) (effect allele A; allele frequency, 0.01) in the F2 gene | ||
thrombophilia.txt · Last modified: 2026/07/07 10:48 by gary1